Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

Safety Information

19-0490

Sigma-Aldrich

Magnesium sulfate heptahydrate

SAJ first grade, ≥99.0%

Synonym(s):

Epsom salts

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
MgSO4 · 7H2O
CAS Number:
10034-99-8
Molecular Weight:
246.47
EC Number:
231-298-2
MDL number:
MFCD00149785
UNSPSC Code:
12352302
PubChem Substance ID:
329751793

grade

SAJ first grade

vapor density

<0.01 (vs air)

vapor pressure

<0.1 mmHg ( 20 °C)

Assay

≥99.0%

form

fine crystals

availability

available only in Japan

pH

5.0-8.0 (50 g/L)

SMILES string

O.O.O.O.O.O.O.[Mg++].[O-]S([O-])(=O)=O

InChI

1S/Mg.H2O4S.7H2O/c;1-5(2,3)4;;;;;;;/h;(H2,1,2,3,4);7*1H2/q+2;;;;;;;;/p-2

InChI key

WRUGWIBCXHJTDG-UHFFFAOYSA-L

Looking for similar products? Visit Product Comparison Guide

Storage Class Code

13 - Non Combustible Solids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

JAN Code

19-0490-8-25KG-J:
19-0490-5-500G-J:

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Ran D Goldman et al.
Pediatrics, 132(6), e1634-e1641 (2013-11-28)
Vaso-occlusive episodes (VOEs) are the most common complication of sickle cell disease in children. Treatment with magnesium seems to improve cellular hydration and may result in reduced vaso-occlusion. This study aimed to determine if intravenous (IV) magnesium sulfate (MgSO4) reduces
D H Salinger et al.
BJOG : an international journal of obstetrics and gynaecology, 120(7), 894-900 (2013-03-28)
To compare magnesium sulphate concentrations achieved by intramuscular and intravenous regimens used for the prevention of eclampsia. Low-resource obstetric hospitals in Nagpur and Vellore, India. Pregnant women at risk for eclampsia due to hypertensive disease. A pharmacokinetic study was performed
Karen J Gibbins et al.
Obstetrics and gynecology, 121(2 Pt 1), 235-240 (2013-01-25)
Clinical trials support the efficacy and safety of magnesium sulfate for cerebral palsy prevention. We evaluated the implementation of a clinical protocol for the use of magnesium for cerebral palsy prevention in our large women's hospital, focusing on uptake, indications
A P Morrison et al.
British journal of anaesthesia, 110(5), 702-712 (2013-03-28)
Spinal anaesthesia is the primary anaesthetic technique for many types of surgery. Adjuncts to the local anaesthetics (LA) used in spinal anaesthesia can exhibit undesirable side-effects, limiting their use, but magnesium may have advantages in this respect. We sought randomized
Chris Chin
Artificial organs, 37(1), 100-102 (2013-01-12)
Congenital heart disease (CHD) is relatively common and there are treatment options for virtually every form of CHD. With good care, the majority of babies can survive to adulthood; however, CHD remains a significant cause of death in infancy and
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service